<?xml version="1.0" encoding="UTF-8"?>
<p>Despite these efforts, the current absence of any approved ACE2-centered therapeutic (to reduce SARS-CoV-2 transmission, COVID-19 progression or halt cardiovascular complications) hints to the need for research in this respect (
 <xref rid="B8" ref-type="bibr">Bhalla et al., 2020</xref>). This is the reason why recent investigations are still ongoing toward developing an ACE2 interactive therapeutic (
 <xref rid="B30" ref-type="bibr">Esparza et al., 2020</xref>; 
 <xref rid="B135" ref-type="bibr">Yahalom-Ronen et al., 2020</xref>) and much more brainstorming is needed.
</p>
